Welcome : Guest

Hutchison China Meditech Ltd. (Hong Kong) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Hutchison China Meditech Ltd., which is principally involved in Biopharmaceuticals Business. Illustrated with 100 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-13032
Price: $3500
Company Type: Public
Pages: 101
Date: November 2016
Market Data Tables: 100

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Hutchison China Meditech Ltd.’s Sales by Business Segment Worldwide (2014-2015) in Percentage for Innovation Platform (Drug Research & Development), and Commercial Platform (Prescription, and Consumer Health)......2
Table 2: Hutchison China Meditech Ltd.’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for Hong Kong, and People’s Republic of China......3
Table 3: Hutchison China Meditech Ltd.’s Sales by Business Segment Worldwide (2013-2014) in Percentage for Health Care, Drug Research & Development and Consumer Products......4
Table 4: Hutchison China Meditech Ltd.’s Sales by Geographic Region Worldwide (2013-2014) in Percentage for Peoples Republic of China and Hong Kong......5
Biopharmaceuticals......6
Table 5: Biopharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Norditropin, NovoSeven, Turoctocog Alpha, and Others......6
Cancer Drugs......7
Table 6: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......7
Table 7: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......8
Cancer Market......9
Table 8: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others......9
Table 9: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......10
Table 10: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......11
Table 11: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......12
Table 12: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......13
Table 13: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......14
Table 14: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......15
Table 15: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......16
Cancer Patients......17
Table 16: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......17
Table 17: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......18
Table 18: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......19
Table 19: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......20
Table 20: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......21
Table 21: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......22
Table 22: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......23
Table 23: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......24
Table 24: Male Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Colon, Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......25
Table 25: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......26
Table 26: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......27
Table 27: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......28
Table 28: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......29
Table 29: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......30
Table 30: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......31
Table 31: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix Uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......32
Table 32: No. of Bladder Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......33
Table 33: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......34
Table 34: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......35
Table 35: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......36
Table 36: No. of Non Small Cell Lung Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......37
Cervical Cancer......38
Table 37: Cervical Cancer Market by HPV Type in England (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 33, HPV 45, and Others......38
Table 38: Cervical Cancer Market by HPV Type in Europe (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 31, HPV 33, and Others......39
Hematological Cancer......40
Table 39: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......40
Skin Cancer......41
Table 40: Skin Cancer by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......41
Cancer-Associated Mucositis......42
Table 41: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......42
Chronic Myelogenous Leukemia (CML)......43
Table 42: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......43
Multiple Myeloma......44
Table 43: Multiple Myeloma by Age Group Worldwide (2015) - Percentage Share Breakdown by No. of New Cases for 45-54, 55-64, 65-74, 75-84, >84, and Others......44
Table 44: Multiple Myeloma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......45
Immunology......46
Table 45: Immunology Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Dermatology, Gastroenterology, and Rheumatology......46
Multiple Sclerosis......47
Table 46: Multiple Sclerosis Disease Occurrence by Type Worldwide (2015) - Percentage Breakdown by Volume for Begin MS, Primary Progressive MS, Relapsing-Remiting MS, and Secondary Progressive MS......47
Table 47: Multiple Sclerosis Patient Care Expenditure by Category Worldwide (2015) - Percentage Breakdown by Value for Adaptations, Ambulatory Care, Disease Modifying Drugs, Early Retirement, Hospital Inpatient Care, Informal Care, Prescription and OTC Drugs, Services, Sick-leave and Redused Working Time, and Tests......48
Table 48: Relapsing-Remitting Multiple Sclerosis (RRMS) Market by Region Worldwide (2015) - Percentage Share Breakdown by Volume for European Union (EU), US, Rest of World (RoW)......49
Table 49: No. of Tcelna (Imilecleucel-T) Secondary Progressive Multiple Sclerosis Patients by Category in the US (2015) - Percentage Breakdown for Primary Progressive MS Patients, Relapsing-Remitting MS Patients, and Secondary-Progressive MS Patients......50
Rheumatoid Arthritis......51
Table 50: Rheumatoid Arthritis Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and Others......51
Neuroendocrine Tumors......52
Table 51: No. of Neuroendocrine Tumours Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......52
Table 52: Neuroendocrine Tumors (NETs) by Area in the US (2015) - Percentage Share Breakdown by Value for Gls & Unknown, Lung & Thymus, and Pancreas......53
Consumer Health Market......54
Table 53: Consumer Health Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Asia-Pacific, Latin America, North America, West European Union and Others......54
Table 54: Consumer Health Market in the US (2015) in US$ Million......55
Table 55: Consumer Healthcare Market by Segments in the US (2015) - Percentage Share Breakdown by Value for Analgesics, Animal Health, Antacids, Cough and Cold, Smoking Aids and Others......56
Inflammatory Bowel Disease (IBD) Drugs......57
Table 56: Inflammatory Bowel Disease (IBD) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Anti-Inflammatory, Biologics, and Immunomodulatory......57
Over the Counter (OTC) Drugs......58
Table 57: OTC Market (Private Label and Others) by Region Worldwide (2015) - Percentage Share Breakdown by Values Sales for Australia, Canada, Chile, France, Germany, Israel, Japan, Netherlands, Russia, United Kingdom, USA and Rest of the World......58
Table 58: OTC Drug Sales by Category in China (2015) - Percentage Market Share Breakdown by Value for Anti-Inflammatory, Cold, Gastrointestinal, Gynecological, Minerals, Tonics, Vitamins, Supplements, and Others......59
Table 59: OTC Drugs Market by Channel in China (2015) - Percentage Share Breakdown by Value Sales for Clinics, Community Hospital, General Hospital, Pharmacy, Supermarket, and Others......60
Table 60: Over - The - Counter (OTC) Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for Cough, Cold, Allergy & Sinus, Digestives, Pain Relief, Vitamins & Supplements, Weight Loss & Nutritional Meal Replacements and Others......61
Therapeutic Drugs......62
Table 61: Therapeutic Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cancer/Onc./Hem., Cardiology, CNS, Dermatology, Diabetes, GI/Ulcer, Infectious Disease, Multiple Sclerosis, Ophthalmology, Respiratory, Rheumatology, Women's Health, and Others......62
Cardiovascular......63
Table 62: Cardiovascular Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......63
Table 63: Cardiology Market by Category in the US (2015) - Percentage Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Anti-Arrhythmics, ARB's, Beta Blockers, Calcium Blockers, Cholesterol, Digitalis, Diuretics, Vasodilators, and Others......64
Antivirals......65
Table 64: Antiviral Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Antiviral Drugs, Monoclonal Antibodies, Vaccines and Others......65
Anti-Psychotics......66
Table 65: Anti-Psychotics Market Worldwide (2015-2020) in US$ '000......66
Table 66: Prescribed Atypical Antipsychotic Market by Type in the US (2015) - Percentage Share Breakdown by Value for 5HT1A Agonist, H1, Antagonist, D2 and 5HT2, D2 and 5HT2A, and Partial D2 Agonist......67
Systemic Lupus Erythematosus with Benlysta......68
Table 67: Systemic Lupus Erythematosus with Benlysta Market by Category in the US (2015) - Percentage Share Breakdown by Value for Mild Systemic Lupus Erythematosus (excluded in target population), Moderate Systemic Lupus Erythematosus, and Severe Systemic Lupus Erythematosus......68
Biopharmaceuticals......69
Table 68: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S.A., and Others......69
Table 69: Market Shares of Leading Biopharmaceutical Companies in the US (2015) - Percentage Market Share Breakdown by Value for Actelion Pharmaceuticals Ltd., Alexion Pharmaceuticals, Inc., Celgene Corporation, Gilead Sciences, Inc., Incyte, Corporation, Isis Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc., and Others......70
Prescription Pharmaceuticals......71
Table 70: Market Shares of Leading Prescription Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Volume Sales for Dexa Medica Group, Interbat Pharmaceutical Industry PT, PT Kalbe Farma, Tbk, PT Sanbe Farma, and Others......71
Table 71: Market Shares of Leading RX Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Eurofarma Laboratórios, Hypermarcas S.A.,Pfizer, Inc., Roche AG, Sanofi - Medley Indústria Farmacêutica Ltda and Others......72
Table 72: Market Shares of Leading Prescription Pharmaceutical Companies in the US (2014) - Percentage Market Share Breakdown by Volume Sales for Actavis Plc, Amneal, Inc., Endo Pharma, Inc., Lupin Pharmaceuticals, Inc., Mylan Labs,Inc., Novartis International AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and Others......73
Table 73: Market Shares of Leading Prescription Drug Companies in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries, Ltd., and Others......74
Table 74: Market Shares of Leading Prescription Drug Companies Spending through Media Ads in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......75
Cancer Drugs......76
Table 75: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......76
Table 76: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......77
Table 77: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......78
Table 78: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......79
Table 79: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......80
Breast Cancer Drugs......81
Table 80: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......81
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......82
Table 81: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......82
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......83
Table 82: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......83
Relapsed/Refractory (RR) Aggressive Non-Hodgkin Lymphoma (aNHL)......84
Table 83: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Others......84
Multiple Sclerosis......85
Table 84: Market Shares of Leading Multiple Sclerosis Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Biogen Idec, Novartis AG, Sanofi S.A., and Others......85
Table 85: Market Shares of Leading Drug Brands for Relapsing-Remitting Multiple Sclerosis (RRMS) Worldwide (2015) - Percentage Breakdown by No. of Patients for Avonex, Betaseron, Copaxone, Gilenya, Laquinimod, Rebif, Tysabri, and Others......86
Table 86: Market Shares of Leading Drug Brands for Relapsing-Remitting Multiple Sclerosis (RRMS) Worldwide (2015) - Percentage Breakdown by Value for Avonex, Betaseron, Copaxone, Gilenya, Laquinimod, Rebif, Tysabri, and Others......87
Consumer Health Products......88
Table 87: Market Shares of Leading Healthcare Products Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Ecolab, Inc. and Others......88
Table 88: Market Shares of Leading Consumer Health Products Manufacturers in Indonesia (2015) - Percentage Share Breakdown by Value for Kalbe Farma Tbk PT, SOHO Group, Tempo Scan Pacific Tbk PT and Others......89
Table 89: Market Shares of Leading Consumer Health Product Producers by Value Sales in the US (2014) - Percentage Breakdown for Bayer AG, General Nutrition Centres, Inc., Glanbia Plc, GlaxoSmithKline Plc, Herbalife Ltd., Johnson & Johnson, Inc., Living Essentials, LLC, Merck & Co, Inc., NBTY, Inc., Novartis AG, Otsuka Holdings Co., Ltd., Pfizer, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Reckitt Benckiser Plc, Sanofi SA, Private Label, and Others......90
Table 90: Market Shares of Leading Consumer Health Product Producers by Value Sales in the US OTC Market (2014) - Percentage Breakdown for Bayer AG, GlaxoSmithKline Plc., Johnson & Johnson Inc., Merck & Co Inc., Novartis AG, Pfizer Inc., Prestige Brands Holdings Inc., Procter & Gamble Co., Reckitt Benckiser Plc., Sanofi S.A., Private Label and Others......91
Table 91: Market Shares of Leading Consumer Health Product Manufacturers in US (2015) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson Inc, Living Essentials, Merck & Co., Inc., NBTY, Inc., Novartis AG, Pfizer Inc, Procter & Gamble Co., Private-Label and Others......92
Over the Counter (OTC) Drugs......93
Table 92: Market Shares of Leading Over the Counter (OTC) Drugs Manufacturers in Brazil (2015) - Percentage Share Breakdown by Value for Abbott Laboratories, GlaxoSmithKline, Johnson & Johnson, Sanofi-Aventis and Others......93
Table 93: Market Shares of Leading Over The Counter (OTC) Drugs Manufacturers in Indonesia (2015) - Percentage Share Breakdown by Value for PT Kalbe Farma and Others......94
Table 94: Market Shares of Leading Over the Counter Drugs Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline-Novartis International AG, Johnson & Johnson and Others......95
Cardiology Therapeutics......96
Table 95: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......96
Therapeutic Drugs......97
Table 96: Market Shares of Leading Therapeutic Providers (Alzheimer's Disease, Bone Diseases, Cardiology, CNS, Dermatology, Diabetes/Metabolic, Epilepsy, G.I./Ulcer, HBV/HCV, Infectious Disease, Multiple Sclerosis, Obesity, Onc./Hematology, Ophthalmology, Orphan Disease, Pain Management, Respiratory, Rheumatology, Sleep Disorders, Urinary Incont., and Women's Health) by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Biogen Idec, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Endo International Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......97
Antipsychotics......98
Table 97: Anti-Psychotic Market by Drug Type Worldwide (2015) - Percentage Share Breakdown by Value for Abilify, Abilify Maintena, Invega Sustenna, Latuda, Risperdal Consta, Seroquel XR, and Others......98
Table 98: Market Shares of Leading Prescribed Atypical Antipsychotic Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Sunovion Pharmaceuticals, Inc., and Johnson & Johnson Private Limited......99
Table 99: Market Shares of Leading Prescribed Atypical Antipsychotic Brands in the US (2015) - Percentage Share Breakdown by Value for Abilify, Invega, Latuda, Risperdal, Seroquel, and Others......100
Table 100: New Prescription Market for Atypical Antipsychotic Drugs in the US (2015) - Percentage Share Breakdown by Value Sales for Abilify (Otsuka/ Bristol-Myers Squibb Company), Fanapt (Novartis), Geodon (Pfizer, Inc.), Invega (Johnson & Johnson), Latuda (Sunovion), Olanzapine (Generic Zyprexa), Risperidone (Generic Risperdal), Saphris (Merck & Company, Inc.), Seroquel (AstraZeneca Plc), and Zyprexa (Eli Lilly and Company)......101